vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $6.1M, roughly 1.3× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs -2.3%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.

CCEL vs IPM — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.3× larger
CCEL
$7.8M
$6.1M
IPM
Growing faster (revenue YoY)
IPM
IPM
+2093.8% gap
IPM
2091.6%
-2.3%
CCEL
Faster 2-yr revenue CAGR
IPM
IPM
Annualised
IPM
54.7%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
IPM
IPM
Revenue
$7.8M
$6.1M
Net Profit
$-3.8M
Gross Margin
77.9%
53.1%
Operating Margin
-50.6%
-13.4%
Net Margin
-48.7%
Revenue YoY
-2.3%
2091.6%
Net Profit YoY
-105.1%
EPS (diluted)
$-0.46
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
IPM
IPM
Q4 25
$7.8M
$6.1M
Q3 25
$7.8M
$6.2M
Q2 25
$7.9M
$5.7M
Q1 25
$8.0M
$5.5M
Q4 24
$8.0M
Q3 24
$8.1M
Q2 24
$8.0M
Q1 24
$7.9M
Net Profit
CCEL
CCEL
IPM
IPM
Q4 25
$-3.8M
Q3 25
$749.4K
$-1.1M
Q2 25
$355.8K
$-1.1M
Q1 25
$282.9K
$808.5K
Q4 24
$-1.9M
Q3 24
$1.1M
Q2 24
$655.8K
Q1 24
$556.2K
Gross Margin
CCEL
CCEL
IPM
IPM
Q4 25
77.9%
53.1%
Q3 25
77.0%
50.7%
Q2 25
76.6%
50.1%
Q1 25
75.1%
55.3%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
IPM
IPM
Q4 25
-50.6%
-13.4%
Q3 25
24.3%
-23.0%
Q2 25
18.8%
-19.7%
Q1 25
13.3%
-24.2%
Q4 24
-1.5%
Q3 24
17.2%
Q2 24
17.3%
Q1 24
10.5%
Net Margin
CCEL
CCEL
IPM
IPM
Q4 25
-48.7%
Q3 25
9.6%
-17.4%
Q2 25
4.5%
-18.3%
Q1 25
3.5%
14.7%
Q4 24
-23.2%
Q3 24
13.0%
Q2 24
8.2%
Q1 24
7.1%
EPS (diluted)
CCEL
CCEL
IPM
IPM
Q4 25
$-0.46
$-0.05
Q3 25
$0.09
$-0.08
Q2 25
$0.04
$-0.08
Q1 25
$0.03
$0.06
Q4 24
$-0.23
Q3 24
$0.13
Q2 24
$0.08
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
IPM
IPM
Cash + ST InvestmentsLiquidity on hand
$3.3M
$5.6M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$18.2M
Total Assets
$61.7M
$26.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
IPM
IPM
Q4 25
$3.3M
$5.6M
Q3 25
$3.2M
$7.3M
Q2 25
$4.4M
$7.3M
Q1 25
$3.5M
$9.7M
Q4 24
$3.5M
Q3 24
$2.1M
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
CCEL
CCEL
IPM
IPM
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
IPM
IPM
Q4 25
$-18.6M
$18.2M
Q3 25
$-14.8M
$18.8M
Q2 25
$-15.6M
$19.9M
Q1 25
$-14.7M
$21.1M
Q4 24
$-13.2M
Q3 24
$-9.6M
Q2 24
$-10.7M
Q1 24
$-10.3M
Total Assets
CCEL
CCEL
IPM
IPM
Q4 25
$61.7M
$26.0M
Q3 25
$63.2M
$27.2M
Q2 25
$64.4M
$29.8M
Q1 25
$64.4M
$31.1M
Q4 24
$64.7M
Q3 24
$62.9M
Q2 24
$62.6M
Q1 24
$61.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
IPM
IPM
Operating Cash FlowLast quarter
$1.3M
$87.6K
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
IPM
IPM
Q4 25
$1.3M
$87.6K
Q3 25
$2.5M
$133.0K
Q2 25
$707.0K
$-888.7K
Q1 25
$954.1K
$1.7M
Q4 24
$2.2M
Q3 24
$2.4M
Q2 24
$1.8M
Q1 24
$-356.9K
Free Cash Flow
CCEL
CCEL
IPM
IPM
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
IPM
IPM
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
IPM
IPM
Q4 25
0.9%
Q3 25
0.5%
0.0%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
2.3%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
IPM
IPM
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
2.16×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCEL
CCEL

Segment breakdown not available.

IPM
IPM

Procurement Revenue$5.4M88%
Other$743.9K12%

Related Comparisons